Clinical Trial Update: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing Mirikizumab and Tirzepatide in adults with moderately to severely active Crohn's disease and obesity or overweight is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Obesity

Drugs mentioned

• Mirikizumab (mirikizumab)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Crohn's Disease, Obesity or Overweight | Phase 3 | Status: RECRUITING